EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Emergency myelopoiesis in solid cancers

Konstantinos Aliazis, Sasitorn Yenyuwadee, Ployploen Phikulsod, Vassiliki A Boussiotis iD

British Journal of Haematology · 2024-09 · 205 (3) · 798-811

DOI: 10.1111/bjh.19656 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Haematology, online erschienen am 23.07.2024. Verfasst von Konstantinos Aliazis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Myelopoiesis, Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cells of the innate and adaptive immune systems are the progeny of haematopoietic stem and progenitor cells (HSPCs). During steady‐state myelopoiesis, HSPC undergo differentiation and proliferation but are called to respond directly and acutely to various signals that lead to emergency myelopoiesis, including bone marrow ablation, infections, and sterile inflammation. There is extensive evidence that many solid tumours have the potential to secrete classical myelopoiesis‐promoting growth factors and other products able to mimic emergency haematopoiesis, and to aberrantly re‐direct myeloid cell development into immunosuppressive cells with tumour promoting properties. Here, we summarize the current literature regarding the effects of solid cancers on HSPCs function and discuss how these effects might shape antitumour responses via a mechanism initiated at a site distal from the tumour microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyelopoiesisNeoplasmsHumansHematopoietic Stem CellsTumor MicroenvironmentAnimals

Stichwörter der Autor:innen

cancerclonal hematopoiesisemergency myelopoiesismyeloid derived suppressor cellsmyelopoiesistumour associated macrophages

Autor:innen und Institutionen

  • Department of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Vassiliki A Boussiotis

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Aliazis, K., Yenyuwadee, S., Phikulsod, P., & Boussiotis, V. A. (2024). Emergency myelopoiesis in solid cancers. British Journal of Haematology, 205(3), 798-811. https://doi.org/10.1111/bjh.19656

Vancouver

Aliazis K, Yenyuwadee S, Phikulsod P, Boussiotis VA. Emergency myelopoiesis in solid cancers. British Journal of Haematology. 2024;205(3):798-811. doi:10.1111/bjh.19656

BibTeX
@article{Aliazis2024,
  author = {Aliazis, Konstantinos and Yenyuwadee, Sasitorn and Phikulsod, Ployploen and Boussiotis, Vassiliki A},
  title = {Emergency myelopoiesis in solid cancers},
  journal = {British Journal of Haematology},
  year = {2024},
  volume = {205},
  number = {3},
  pages = {798--811},
  doi = {10.1111/bjh.19656}
}
Kostenlos starten →